LU86484A1 - Sels de furosemide - Google Patents

Sels de furosemide Download PDF

Info

Publication number
LU86484A1
LU86484A1 LU86484A LU86484A LU86484A1 LU 86484 A1 LU86484 A1 LU 86484A1 LU 86484 A LU86484 A LU 86484A LU 86484 A LU86484 A LU 86484A LU 86484 A1 LU86484 A1 LU 86484A1
Authority
LU
Luxembourg
Prior art keywords
furosemide
quaternary ammonium
choline
tetra
arylammonium
Prior art date
Application number
LU86484A
Other languages
English (en)
French (fr)
Inventor
Lester Chafetz
Jose Philip
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of LU86484A1 publication Critical patent/LU86484A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
LU86484A 1985-07-02 1986-06-20 Sels de furosemide LU86484A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75176385 1985-07-02
US06/751,763 US4663348A (en) 1985-07-02 1985-07-02 Furosemide salts and pharmaceutical preparations thereof

Publications (1)

Publication Number Publication Date
LU86484A1 true LU86484A1 (fr) 1986-12-02

Family

ID=25023379

Family Applications (1)

Application Number Title Priority Date Filing Date
LU86484A LU86484A1 (fr) 1985-07-02 1986-06-20 Sels de furosemide

Country Status (14)

Country Link
US (1) US4663348A (da)
JP (1) JPS625975A (da)
AU (1) AU599034B2 (da)
BE (1) BE904986A (da)
CH (1) CH670448A5 (da)
DE (1) DE3619665A1 (da)
DK (1) DK312586A (da)
FR (1) FR2584405B1 (da)
GB (1) GB2189239B (da)
IT (1) IT1191972B (da)
LU (1) LU86484A1 (da)
NL (1) NL8601519A (da)
SE (1) SE8602917L (da)
ZA (1) ZA864207B (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4920145A (en) * 1988-02-29 1990-04-24 Gaf Chemical Corporation Water-soluble complexes of water-insoluble pharmaceutical compounds and preparation thereof
IT1237115B (it) * 1989-10-24 1993-05-18 Sali della furosemide, procedimento per la loro preparazione e composizionni farmaceutiche che li contengono
DE69118716T2 (de) * 1991-12-03 1996-12-19 Kokuyo Kk Beidseitig zu öffnende/verschliessende vorrichtung zum ordnen
US7214711B2 (en) * 1998-12-23 2007-05-08 Neurotherapeutics Pharma Llc Method of treating migraine headache without aura
US8722668B2 (en) * 1998-12-23 2014-05-13 Daryl W. Hochman Methods and compositions for the treatment of neuropathic pain and neuropsychiatric disorders
US8008283B2 (en) * 1998-12-23 2011-08-30 Neurotherapeutics Pharma, Inc. Methods and compositions for the treatment of neuropsychiatric disorders
FI114538B (fi) * 2001-01-12 2004-11-15 Finnfeeds Finland Ltd Glysiinibetaiinin käyttö verenpainetta alentavan tuotteen valmistukseen
US6989386B2 (en) * 2002-04-30 2006-01-24 Dana-Farber Cancer Institute Pharmaceutically active ornithine derivatives, ammonium salts thereof and methods of making same
US9169266B2 (en) * 2010-02-10 2015-10-27 Kissei Pharmaceutical Co., Ltd. Salt of fused heterocyclic derivative and crystal thereof
EP3799869A1 (en) * 2013-04-05 2021-04-07 ScPharmaceuticals Inc. Pharmaceutical formulations for subcutaneous administration of furosemide
US11246851B2 (en) 2019-01-04 2022-02-15 Sq Innovation Ag Pharmaceutical compositions of furosemide and uses thereof
KR20210150360A (ko) 2019-01-31 2021-12-10 에스씨파마슈티칼스 인코포레이티드 푸로세미드의 농축된 액체 제약 제제 및 그의 투여 방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3058882A (en) * 1959-12-28 1962-10-16 Hoechst Ag N'-substituted-3-carboxy-6-halo-sulfanilamide and derivatives thereof
US3565920A (en) * 1966-12-29 1971-02-23 Ciba Geigy Corp 5-sulfamyl-anthranilic acids
DK138322B (da) * 1970-07-13 1978-08-14 Dumex Ltd As Fremgangsmåde til fremstilling af N-substituered antranilsyrederivater.
FR2210607A1 (en) * 1972-12-20 1974-07-12 Aries Robert 4-Chloro-5-sulphamoyl-N-furfuryl-anthranilic acid prepn. - from furfural and 4-chloro-5-sulphamoyl anthranilic acid
DE2343218C2 (de) * 1973-08-28 1986-08-07 Hoechst Ag, 6230 Frankfurt Furosemid enthaltende Pellets
LU74319A1 (da) * 1976-02-09 1977-08-19
DE3025367A1 (de) * 1980-07-04 1982-01-28 Hoechst Ag, 6000 Frankfurt Salz aus furosemid oder piretanid als saeurekomponente und penbutolol oder (-)-3-(4- (3-(3,4-dimethoxyphenylaethylamino)-2-hydroxy-propoxy) -phenyl ) -crotonsaeurenitril als basenkomponente, verfahren zu seiner herstellung, dieses enthaltendes mittel und dessen verwendung

Also Published As

Publication number Publication date
US4663348A (en) 1987-05-05
GB2189239A (en) 1987-10-21
IT8648183A0 (it) 1986-06-25
DE3619665A1 (de) 1987-01-08
GB8615275D0 (en) 1986-07-30
FR2584405B1 (fr) 1989-02-24
BE904986A (fr) 1986-12-24
AU5889086A (en) 1987-01-08
GB2189239B (en) 1989-02-01
FR2584405A1 (fr) 1987-01-09
IT1191972B (it) 1988-03-31
AU599034B2 (en) 1990-07-12
DK312586A (da) 1987-01-03
CH670448A5 (da) 1989-06-15
SE8602917L (sv) 1987-01-03
DK312586D0 (da) 1986-07-01
SE8602917D0 (sv) 1986-07-01
NL8601519A (nl) 1987-02-02
ZA864207B (en) 1987-02-25
JPS625975A (ja) 1987-01-12

Similar Documents

Publication Publication Date Title
CA1203242A (fr) Procede de preparation de sels derives de l'acide 3- hydroxybutanoique et d'une base organique aminee, et les sels ainsi obtenus
RU2128160C1 (ru) Трометаминная соль (+)-(s)-2-(3-бензоилфенил)пропионовой кислоты, способ ее получения, фармацевтическая композиция
EP0233106B1 (fr) (-)-Benzhydrylsulfinylacétamide, procédé de préparation et utilisation en thérapeutique
LU83423A1 (fr) Pneumatique radial pour vehicules tout-terrain
LU86484A1 (fr) Sels de furosemide
FR2914188A1 (fr) Nouvelle composition a base d'oxime de cholest-4-en-3-one
CH668594A5 (fr) Preparations parenterales de phenytoine.
CA1242458A (fr) Ethers-oxydes et ethers-oximes d'alcoylaminoalcools comme medicaments, produits nouveaux et procedes pour leur preparation
LU86403A1 (fr) 5-pyrimidine-carboxamides et traitement de la leucemie et des tumeurs avec ces derniers
LU82360A1 (fr) Compositions injectables a base d'oxytetracycline
EP0092287B2 (fr) Sels d'acétylcystéine, leur préparation et leur utilisation
CA2064999A1 (fr) Derives de la 5-amino-1,2,3,4 tetrahydro-acridine et utilisation comme medicaments
FR2620450A1 (fr) Nouveaux sels de composes organogermaniques et medicaments les contenant
LU83928A1 (fr) Acides amino-2 halogenobenzoyl-3 methyphenylacetiques et leurs esters et sels utiles comme medicaments anti-inflammatoires et analgesiques
EP0356325B1 (fr) Composition pharmaceutique comportant un principe actif peu soluble dans l'eau et au moins un glycéride gélifié par au moins un polymère cellulosique
EP0737508A1 (fr) Utilisation d'un composé hydrofluorocarboné dans une émulsion, émulsion et composition comprenant un tel composé
EP0209511B1 (fr) Chlorhydrates de chlorures de dérivés d'aminoalkyl-2 hydroxy-9 ellipticinium et compositions pharmaceutiques en contenant
FR2594439A1 (fr) Nouveaux derives ester, thioester et amide de quinolone, leur procede de preparation et leur application en therapeutique
JPH0144172B2 (da)
BE1001262A4 (fr) Procede en vue de provoquer la regression de la leucemie et l'inhibition de la croissance des tumeurs chez les mammiferes.
EP0729749B1 (fr) Compositions pharmaceutiques comprenant des dérivés de dinoréburnaménine
CH622023A5 (en) Process for the preparation of a water-soluble compound based on a substituted phenylaminoalcohol
BE1001263A4 (fr) Procede en vue de provoquer la regression de la leucemie et l'inhibition de la croissance des tumeurs chez les mammiferes.
FR2507180A1 (fr) Nouvelles phenylalkylamines, leur preparation et leur application comme medicaments
LU83081A1 (fr) Compositions antitumeurs